Abstract
The use of intravenous (i.v.) antihypertensives in the treatment of cardiovascular-related hypertensive emergencies crosses distinct areas of clinical care and therapeutic applications. From first contact with emergency medical services (EMS) personnel, through the entire course of patient evaluation and care to medication considerations at the time of discharge, the applications for the i.v. antihypertensives are multiple and varied. This article describes the frequently encountered cardiovascular-related conditions found in their respective clinical settings and the utility of various antihypertensive treatment options.
Keywords: Hypertensive emergencies, intravenous antihypertensives, cardiovascular, acute coronary syndrome (ACS), perioperative hypertension, abdominal aortic aneurysm, catecholamine excess, deliberate hypotension
Current Vascular Pharmacology
Title: Intravenous Antihypertensives within Cardiovascular-Based Continuity of Care
Volume: 7 Issue: 2
Author(s): Joseph Varon and Albert T. Cheung
Affiliation:
Keywords: Hypertensive emergencies, intravenous antihypertensives, cardiovascular, acute coronary syndrome (ACS), perioperative hypertension, abdominal aortic aneurysm, catecholamine excess, deliberate hypotension
Abstract: The use of intravenous (i.v.) antihypertensives in the treatment of cardiovascular-related hypertensive emergencies crosses distinct areas of clinical care and therapeutic applications. From first contact with emergency medical services (EMS) personnel, through the entire course of patient evaluation and care to medication considerations at the time of discharge, the applications for the i.v. antihypertensives are multiple and varied. This article describes the frequently encountered cardiovascular-related conditions found in their respective clinical settings and the utility of various antihypertensive treatment options.
Export Options
About this article
Cite this article as:
Varon Joseph and Cheung T. Albert, Intravenous Antihypertensives within Cardiovascular-Based Continuity of Care, Current Vascular Pharmacology 2009; 7 (2) . https://dx.doi.org/10.2174/157016109787455590
DOI https://dx.doi.org/10.2174/157016109787455590 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vascular Pleiosynergy - Does It Really Work?
Current Vascular Pharmacology Mitochondrial MMP Activation, Dysfunction and Arrhythmogenesis in Hyperhomocysteinemia
Current Vascular Pharmacology Molecularly Imprinted Polymers for Selective Solid-Phase Extraction of Verapamil from Biological Fluids and Human Urine
Current Pharmaceutical Analysis Editorial [Hot Topic (1): Update on Inflammatory Processes Governing Atherosclerotic Plaque Vulnerability and Reperfusion Injury (Guest Editors: Fabrizio Montecucco and Francois Mach)]
Current Pharmaceutical Biotechnology Hypothyroidism and Atherosclerosis-Possible Implication of the Renin-Angiotensin System
Current Hypertension Reviews Potential Therapeutic Targets in Cirrhotic Cardiomyopathy
Cardiovascular & Hematological Disorders-Drug Targets Polyphenols-Rich Natural Products for Treatment of Diabetes
Current Medicinal Chemistry Stem Cell Therapy in Chronic Obstructive Pulmonary Disease. Seeking the Prometheus Effect
Current Drug Targets Direct and Indirect Measurement of Temporal Horn Volume and Temporal Horn Index and its Neuropsychological Correlation in Mild Cognitive Impaired and Alzheimer Diseased Patients
Current Medical Imaging Pleiotropic Effects of ARB in Diabetes Mellitus
Current Vascular Pharmacology The Mediterranean Diet: A Combination of Beneficial Elements for Cardiovascular Disease
Current Nutrition & Food Science Adynamic Ileus Induced by Varenicline
Current Drug Safety Innate Immunity and the Heart
Current Pharmaceutical Design TGF-beta Signaling in Cancer Treatment
Current Pharmaceutical Design Novel Drugs for Hypertension and Heart Failure: Struggling for a Place Under the Sun
Current Pharmaceutical Design Effects of Honey Against the Accumulation of Adipose Tissue and the Increased Blood Pressure on Carbohydrate-Induced Obesity in Rat
Letters in Drug Design & Discovery Pharmacotherapeutic Approach to Prevent or Treat Chronic Allograft Nephropathy
Current Drug Targets - Cardiovascular & Hematological Disorders Mind-Body Therapies and Osteoarthritis of the Knee
Current Rheumatology Reviews Prostacyclin Synthase Gene: Implication and Prevention of Cardiovascular Disease
Vascular Disease Prevention (Discontinued) Preface: (Commentary on the Special Issue on the Impact of Myogenic Tone in Health and Disease)
Current Vascular Pharmacology